Abstract
Dengue and chikungunya have been endemic in India but have the tendency to cause periodic epidemics, often together, wherein they are termed ‘syndemic’. Such a syndemic was observed in 2016 in India which resulted in a further scarcity of already resource-poor specific diagnostic infrastructure even in many urban conglomerates. A cross-sectional study was thus conducted, on 978 fever patients that consulted the ICMR-NIMR fever clinic, New Delhi, in September 2016, with an objective to identify symptom/s that could predict chikungunya with certainty. The overall aim was to rationally channelize the most clinically suitable patients for the required specific diagnosis of chikungunya. Based on their clinical profile, febrile patients attending NIMR’s clinic, appropriate laboratory tests and their association analyses were performed. Bivariate analysis on 34 clinical parameters revealed that joint pain, joint swelling, rashes, red spots, weakness, itching, loss of taste, red eyes, and bleeding gums were found to be statistically significantly associated predictors of chikungunya as compared to dengue. While, in multivariate analysis, only four symptoms (joint pain in elbows, joint swelling, itching and bleeding gums) were found in statistically significant association with chikungunya. Hence, based on the results, a clinician may preferably channelize febrile patients with one or more of these four symptoms for chikungunya-specific diagnosis and divert the rest for dengue lab diagnosis in a dengue–chikungunya syndemic setting.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Background
Arboviral diseases (AVDs) contribute to sizeable burden globally [1] and particularly dengue and chikungunya have major public health importance in India. With similar agent-host-vector-time relationships, it is highly plausible that dengue and chikungunya viruses co-circulate in the same geo-temporal dimension and generate a febrile syndemic leading to clinical ambiguity in specific diagnosis [2, 3]. General clinical features of dengue and chikungunya are so indifferent that these diseases are often collectively named as dengue/break bone fever or chikungunya fever is even misdiagnosed as dengue fever [4, 5] further aggravating the diagnostic dilemma [6].
Chikungunya virus (CHIKV) usually manifests clinically as an acute self-remitting triad of fever, pruriginous maculopapular rash, and arthralgia (joint pains). Although arthralgia has been noted as a clinical ‘marker’ of chikungunya [7, 8], reports have debated this due to variability of its presentation in chikungunya [9], its presence in other AVDs [10], including dengue [11], and also due to variations in clinical acumen in diagnosing arthralgia vis-à-vis arthritis, rheumatism, and musculoskeletal pains. The chikungunya-associated arthralgia generally is a migratory polyarthralgia with pain on movement, involves small/large joints of extremities, and is usually symmetric [12,13,14,15,16]. Persistent arthralgia (≥ 3 months) has some differential diagnostic importance but its clinical applicability is limited due to recall bias and association with non-infectious co-morbidities [17, 18]. Confirmatory lab diagnosis is important as non-steroidal anti-inflammatory drugs are contraindicated in dengue, but can be safely prescribed for chikungunya-associated arthralgias.
Routine laboratory diagnoses are non-specific. Enzyme-linked immunosorbent assays (ELISA) for IgM and detection of viral gene/s (E1 by RT-PCR) are helpful but their interpretations warrant thorough understanding of period of viremia and immunity [19, 20] as DENV NS1 is detectable up to 5 days and DENV/CHIKV IgM is detected only after 5–7 days of symptom onset and there are concerns with cross-reactivity between closely-related viruses. Additionally, IgM antibodies remain detectable for up to 3 months after symptoms develop [21, 22]. CHIKV RNA by RT-PCR [23,24,25,26] is positive only within 3–6 days of onset [27] and its use is limited as most patients report late to health facilities. Virus isolation [28] remains the gold-standard confirmatory diagnosis and PCR-based tests are costly and have high diagnostic turnover time. A few rapid point-of-care diagnostics are available but their utility is limited by poor performance [29, 30].
The problem is magnified many-folds in resource-poor settings as they bear the major brunt of AVDs. Developing a clinical diagnostic algorithm can increase the specificity of a likely diagnosis [31] and channelize selected patients for confirmatory diagnosis that aid in efficient allocation of resources. Therefore, the aim of this study was to identify certain clinical features that could predict chikungunya over dengue in a syndemic setting.
2 Methods
Approval (NIMRWEC/2021/06–01) to perform analysis was taken from the Institutional Ethics Committee of ICMR-National Institute of Malaria Research (ICMR-NIMR), New Delhi, India. We performed a cross-sectional analysis on the available clinical data of patients who came with fever at the clinic of ICMR-NIMR, New Delhi in September 2016. We used patients’ clinical records for labeling a case as probable dengue, probable chikungunya, or both. The clinic observed a standard protocol wherein patients with fever duration ≤ 5 days were tested for dengue NS1 antigen (Panbio Dengue Early ELISA kit, Standard Diagnostics Inc., Republic of S. Korea) and those with fever for > 5 days were tested for dengue- and chikungunya-specific IgM antibodies (MAC ELISA kit supplied by ICMR-National Institute of Virology, Pune, India). All tests were performed as per the manufacturers’ instructions and samples with > 11 Panbio units were interpreted as dengue NS1 positive. For IgM ELISA, sample optical density (OD) was taken at 450 nm and samples with OD ≥ three times the OD of negative control were considered as “positive”. Lab diagnosis was correlated with clinical features suggestive of chikungunya and dengue.
We used Stata 15 (StataCorpStata Statistical Software: Release 16. College Station, TX: StataCorp LLC) for data analyses wherein continuous variables were compared using analysis of variance if they followed normal distribution, else Kruskal–Wallis test was performed. All categorical variables were compared using the chi-square/Fisher exact test.
Independent variables included four non-clinical (age, gender, marital status, education, duration of fever) and 39 clinical parameters whereas dependent variables included the following four categories: only-dengue (NS1 antigen and/or dengue IgM positive but chikungunya IgM negative), only-chikungunya (NS1 antigen and dengue IgM negative but chikungunya IgM positive), both dengue and chikungunya (NS1 antigen and/or dengue IgM positive and chikungunya IgM positive), neither dengue nor chikungunya (NS1 antigen and dengue IgM negative and chikungunya IgM negative). We used bivariate analysis for estimating the association between variables followed by multivariate analysis on those variables that were found statistically significant in the bivariate analysis at 5% level of significance (p value < 0.05 was considered statistically significant). Direction and strength of the association were estimated by calculating the relative risk ratio (RRR) using logistic regression.
3 Results
A total of 978 patients with fever or a history thereof were reported in the fever clinic of ICMR-NIMR, New Delhi in September 2016. The socio-demographic descriptive profile of patients is shown in Table 1 whereas the association of relevant socio-demographic variables and duration of fever with four dependent outcomes is shown in Table 2. Out of 978, ~ 56% patients were male and ~ 60% (588) were only educated up to higher secondary level with 17% never attended any formal schooling. Almost 50% of the patients had no formal employment. Among 978 patients, 541 (55%) patients had neither dengue nor chikungunya; 23 (2%) had only-dengue, 340 (35%) had only-chikungunya and 74 (8%) patients were found positive for both dengue and chikungunya. The mean age of the patients varied significantly between these four clinical outcomes with higher mean age for chikungunya infections either alone (31.1 years) or with dengue (29.4 years). The mean duration of fever also differed between these groups with lesser duration (5 days; 3–8 days’ range) in patients who neither had dengue nor chikungunya.
We noted 13 out of 39 independent clinical variables (33%) to be in statistically significant positive association (predictors) with only-chikungunya in bivariate analysis (Table 3). These included, in decreasing order of predictor RRRs, in brackets: bleeding gums (4.56), joint swelling (3.24), fever with joint pain in general (3.0), itching (2.93), rash (2.71), red spots (2.47), joint pain in hands (2.11), joint pain in elbows (1.96), loss of taste (1.72), red eyes (1.70), joint pain in ankles (1.62), joint pain in wrists (1.56), and weakness (1.35). Out of these, only joint pain in general (4.06), weakness (2.90), joint swelling (2.82), joint pain in elbows (2.34), rashes (2.25), and itching (1.76) and in addition pain in chest (3.40) were significantly associated with patients with both dengue and chikungunya. Only four clinical features (red eyes, photophobia, vomiting sensation and bleeding gums) were positively associated with only-dengue. Subsequently multivariate analyses (Table 4) on the 13 variables positively associated with chikungunya alone revealed that the most significant chikungunya predictors include: bleeding gums (RRR 6.23; 95% CI 1.29–30.07), joint swelling (RRR 1.95; 95% CI 1.35–2.80), itching (RRR 1.89; 95% CI 1.31–2.73), and joint pain in elbows (RRR 1.70; 95% CI 1.17–2.48) as were found statistically significantly associated with chikungunya only. Joint pain in elbows was also found significantly associated with both chikungunya and dengue (RRR 1.85; 95% CI 1.20 to 3.34). Weakness had significantly association with both dengue and chikungunya with RRR of 1.9 (95% CI 1.05–3.45). None of the 13 variables were found to be associated with dengue only. The positive predictive value (PPV) of all the four clinical parameters in detecting chikungunya over dengue was found to be > 90% with joint swelling having the highest PPV of 98.5%, followed by elbow pain (96.5%), joint pain (95%), itching (94.6%) and bleeding gums (91.7%).
4 Discussion
We found that a little less than half of the patients examined had chikungunya which justifies the need for a clinical predictor and we conclude that 4 clinical features (bleeding gums, joint swelling, itching, and joint pain in elbow) significantly increased the risk of having only CHIKV infection.
Joint involvement in chikungunya has been reported previously [32,33,34,35,36,37,38,39,40,41,42] but the sites were either not considered or differed between studies. Previous studies indicated that hands, wrist and ankles [43] or knees [44,45,46,47] were the most affected joints in chikungunya and could be one of its strongest predictors. This study reveals elbow pain (over other joints) as the most significant predictor of chikungunya. Although elbow pain was also significantly associated with patients having dengue and chikungunya both, it was not found associated with dengue only and therefore is highly plausible to be specific to chikungunya. The specificity and PPV of arthralgia has been reported to be ~ 99% and 85%, respectively [12] although dengue was not considered in this study. This study shows that the PPV of febrile arthralgia (irrespective of the type of joint involved) and pain in elbows (over other joints) correspond to 95% and 96.5%, respectively, when compared with dengue and therefore suggests their use as a strong predictor of chikungunya. However, the subjectivity of joint pains could be misleading as compared to joint swelling when it comes to selective prediction of chikungunya and, therefore, joint swelling could be a more valid clinical predictor than arthralgia [35] with a PPV of 98.5% as reported in this study.
Itching/pruritus (RRR 2.9; PPV 94.6%) also comes out to be a good clinical predictor of chikungunya. Studies have also reported pruritus to be significantly associated with chikungunya [12] but other AVDs including dengue were not compared. An Indian study reported itching in 50% of chikungunya cases but its use as clinical predictor of chikungunya in syndemics has not been evaluated [48]. Only one study could be found that concluded that pruritic skin was a clinical predictor of chikungunya against other febrile illnesses and dengue [40]. Bleeding gums (RRR 6.23; p < 0.05) emerged out to be the strongest predictor (highest RRR) of chikungunya in this study. Not many studies have examined this but those that did, they focused on examination of oral manifestations of chikungunya. Oral lesions common in chikungunya with gingival bleeding amongst the top few manifestations [38, 49, 50]. However, bleeding manifestations are more often associated with dengue [34] that are less common in chikungunya [51] and despite significant association with chikungunya, it would not be clinically apt to use it as its predictor in a dengue–chikungunya syndemic setting. Further, the analyses have a limitation: bleeding gums was more strongly associated with dengue-only as compared to chikungunya-only group (RRR 8.15 versus 4.56; Table 2) along with photophobia and vomiting sensation that were found associated with dengue-only group and not with chikungunya. Multivariate analyses were done only on 13 variables that were associated with chikungunya only and hence did not consider photophobia and vomiting sensation. In addition, only 3% of chikungunya cases (11/338) had bleeding gums against 4% in dengue (1/23) and due to lesser number of events, the association might have been over-estimated.
Other symptoms including fever [45, 46, 52], polyarthralgia [12, 52], joint swelling [47] were also reported among CHIKV infected population in past studies. The presence of myalgia [12, 47, 53] was also observed among CHIKV-infected population but recent clinical records were unable to find any significant association with chikungunya.
5 Conclusion
Segregating and prioritizing cases for chikungunya-specific lab diagnosis might be effective in dengue syndemic resource-limited settings. Although limited by the number of patients with dengue only, the findings from this study do conclude that joint involvement (joint pain in general, pain in elbows and joint swelling) can strongly predict, either singly or together, chikungunya for confirmatory diagnosis. Itching and bleeding gums can also predict chikungunya but they deserve further evaluation.
Availability of Data and Materials
The data may be made available on a reasonable request.
Abbreviations
- AVDs:
-
Arboviral diseases
- CHIKV:
-
Chikungunya virus
- CI:
-
Confidence interval
- DENV:
-
Dengue virus
- ELISA:
-
Enzyme-linked immunosorbent assays
- IFA:
-
Indirect immunofluorescence assays
- NS1 antigen:
-
Non-structural 1 antigen
- OD:
-
Optical density
- OPD:
-
Out-patient department
- PPV:
-
Positive predictive value
- RRR:
-
Relative risk ratio
- RT-PCR:
-
Reverse transcriptase PCR
References
Liang G, Gao X, Gould EA. Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect. 2015;4(3): e18.
Nuckols JT, Huang YJS, Higgs S, Miller AL, Pyles RB, Spratt HM, et al. Evaluation of simultaneous transmission of chikungunya virus and dengue virus type 2 in infected Aedes aegypti and Aedes albopictus (diptera: Culicidae). J Med Entomol. 2015;52(3):447–51.
Furuya-Kanamori L, Liang S, Milinovich G, Soares Magalhaes RJ, Clements ACA, Hu W, et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis. 2016. https://doi.org/10.1186/s12879-016-1417-2.
Petersen LR, Powers AM. Chikungunya:epidemiology. F1000Res. 2016;5:82.
Christie J. On epidemics of dengue fever: their diffusion and etiology. Glasgow Med J. 1881;XVI(3):161.
Lo Presti A, Cella E, Angeletti S, Ciccozzi M. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: an updating review. Infect Genet Evol. 2016;41:270–8.
Carey Donald E. Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci. 1971;26(3):262.
Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of chikungunya virus infection on Réunion Island, France, 2005–2006. Am J Trop Med Hyg. 2007;77(4):727–31.
Nimmannitya S, Halstead SB, Cohen SN, Margiottai MR. Dengue and Chikungunya Virus Infection in Man in Thailand, 1962–1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969;18(6):954–71.
Kuno G. A re-examination of the history of etiologic confusion between dengue and chikungunya. PLoS Negl Trop Dis. 2015;9(11): e0004101.
Wali JP, Biswas A, Handa R, Aggarwal P, Wig N, Dwivedi SN. Dengue haemorrhagic fever in adults: a prospective study of 110 cases. Trop Doct. 1999;29(1):27–30.
Staikowsky F, Talarmin F, Grivard P, Souab A, Schuffenecker I, Le Roux K, et al. Prospective study of chikungunya virus acute infection in the Island of La Réunion during the 2005–2006 outbreak. PLoS ONE. 2009;4(10): e7603.
Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, et al. Chikungunya infection in travelers. Emerg Infect Dis. 2006;12(10):1565–7.
Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–1953. Trans R Soc Trop Med Hyg. 1955;49(1):28–32.
Lam SK, Chua KB, Hooi PS, Rahimah MA, Kumari S, Tharmaratnam M, et al. Chikungunya infection–an emerging disease in Malaysia Southeast Asian. J Trop Med Public Health. 2001;32(3):447–51.
Saxena S, Singh M, Mishra N, Lakshmi V. Resurgence of chikungunya virus in India: an emerging threat. Euro Surveill. 2006;11(8):E060810.2.
González D, Martínez R, Castro O, Serrano T, Portela D, Vazquez S, et al. Evaluation of some clinical, humoral and imagenological parameters in patients of dengue haemorrhagic fever six months after acute illness. Dengue Bull. 2005;29:79–84.
García G, González N, Pérez AB, Sierra B, Aguirre E, Rizo D, et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis. 2011;15(1):e38-43.
Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev. 1994;58(3):491–562.
Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol. 2013;36(3):211–27.
Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods. 2008;149(1):175–9.
Sam I-C, AbuBakar S. Chikungunya virus infection. Med J Malays. 2006;61(2):264–9.
Hasebe F, Parquet MC, Pandey BD, Mathenge EGM, Morita K, Balasubramaniam V, et al. Combined detection and genotyping of Chikungunya virus by a specific reverse transcription-polymerase chain reaction. J Med Virol. 2002;67(3):370–4.
Pfeffer M, Linssen B, Parker MD, Kinney RM. Specific detection of Chikungunya virus using a RT-PCR/nested PCR combination. J Vet Med Ser B. 2002;49(1):49–54.
Pastorino B, Bessaud M, Grandadam M, Murri S, Tolou HJ, Peyrefitte CN. Development of a TaqMan® RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J Virol Methods. 2005;124(1–2):65–71.
Carletti F, Bordi L, Chiappini R, Ippolito G, Sciarrone MR, Capobianchi MR, et al. Short report: rapid detection and quantification of chikungunya virus by a one-step reverse transcription-polymerase chain reaction real-time assay. Am J Trop Med Hyg. 2007;77(3):521–4.
Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya: epidemiology, pathogenesis, clinical features, management, and prevention. Infect Dis Clin N Am. 2019;33(4):1003–25.
Panning M, Grywna K, Van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean Region, 2006. Emerg Infect Dis. 2008;14(3):416–22.
Sam IC, Kümmerer BM, Chan YF, Roques P, Drosten C, AbuBakar S. Updates on chikungunya epidemiology, clinical disease, and diagnostics. Vector-Borne Zoonotic Dis. 2015;15(4):223–30.
McSweegan E, Weaver SC, Lecuit M, Frieman M, Morrison TE, Hrynkow S. The global virus network: challenging chikungunya. Antiviral Res. 2015;120:147–52.
Deribe K. Developing and validating a clinical algorithm for the diagnosis of podoconiosis. Trans R Soc Trop Med Hyg. 2020;114(12):916–25.
Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya Virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3): e2137.
Shahid U, Farooqi JQ, Barr KL, Mahmoodid SF, Jamil B, Imitaz K, et al. Comparison of clinical presentation and out-comes of Chikungunya and Dengue virus infections in patients with acute undifferentiated febrile illness from the Sindh Region of Pakistan. PLoS Negl Trop Dis. 2020;14(3): e0008086.
Lee VJ, Chow A, Zheng X, Carrasco LR, Cook AR, Lye DC, et al. Simple clinical and laboratory predictors of chikungunya versus dengue infections in adults. PLoS Negl Trop Dis. 2012;6(9): e1786.
Batista RP, Hökerberg YHM, de Oliveira R de VC, Lambert Passos SR. Development and validation of a clinical rule for the diagnosis of chikungunya fever in a dengue-endemic area. PLoS ONE. 2023;18(1):e0279970.
de Souza TMA, de Lima RC, Solórzano VEF, Damasco PV, de Souza LJ, Sanchez-Arcila JC, et al. Was it chikungunya? Laboratorial and clinical investigations of cases occurred during a triple arboviruses’ Outbreak in Rio de Janeiro, Brazil. Pathogens. 2022;11(2):245.
Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal. India Am J Trop Med Hyg. 2012;86(4):720–3.
Casais PM, Akrami K, Cerqueira-Silva T, Moraesc LP, Rigaud VN, Neto ES, et al. Oral lesions are frequent in patients with Chikungunya infection. J Travel Med. 2020;27(4):taaa040.
Kularatne SAM, Gihan MC, Weerasinghe SC, Gunasena S. Concurrent outbreaks of Chikungunya and Dengue fever in Kandy, Sri Lanka, 2006–07: a comparative analysis of clinical and laboratory features. Postgrad Med J. 2009;85(1005):342–6.
Alvarado LI, Lorenzi OD, Torres-Velásquez BC, Sharp TM, Vargas L, Muñoz-Jordán JL, et al. Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012–2015. PLoS Negl Trop Dis. 2019;13(7): e0007562.
Carabali M, Lim JK, Palencia DC, Lozano-Parra A, Gelvez RM, Lee KS, et al. Burden of dengue among febrile patients at the time of chikungunya introduction in Piedecuesta. Colombia Trop Med Int Health. 2018;23(11):1231–41.
MohdZim MA, Sam IC, Omar SFS, Chan YF, AbuBakar S, Kamarulzaman A. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol. 2013;56(2):141–5.
Rueda JC, Santos AM, Angarita J, Giraldo RB. Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014–2015. Emerg Microbes Infect. 2019;8(1):1490–500.
Ball JD, Elbadry MA, Telisma T, White SK, Chavannes S, Anilis MG, et al. Clinical and epidemiologic patterns of chikungunya virus infection and coincident arboviral disease in a school cohort in Haiti, 2014–2015. Clin Infect Dis. 2019;68(6):919–26.
Huits R, De Kort J, Van Den Berg R, Chong L, Tsoumanis A, Eggermont K, et al. Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia. PLoS ONE. 2018;13(4): e0196630.
Anwar S, TaslemMourosi J, Khan MF, Ullah MO, Vanakker OM, Hosen MJ. Chikungunya outbreak in Bangladesh (2017): Clinical and hematological findings. PLoS Negl Trop Dis. 2020;14(2): e0007466.
Sengupta S, Mukherjee S, Haldar SK, Bhattacharya N, Tripathi A. Re-emergence of Chikungunya virus infection in Eastern India. Brazilian J Microbiol. 2020;51(1):177–82.
Vijayakumar KP, Nair Anish TS, George B, Lawrence T, Muthukkutty SC, Ramachandran R. Clinical profile of Chikungunya patients during the epidemic of 2007 in Kerala. India J Glob Infect Dis. 2011;3(3):221–6.
Katti R, Shahapur PR, Udapudi KL. Impact of Chikungunya virus infection on oral health status: an observational study. Indian J Dent Res. 2011;22(4):613.
Brostolin da Costa D, De-Carli AD, Probst LF, Grande AJ, Guerrero ATG. Oral manifestations in chikungunya patients: a systematic review. PLoS Negl Trop Dis. 2021;15(6):e0009401.
Goupil BA, Mores CN. A review of chikungunya virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis. Open Rheumatol J. 2019;10(1):129–40.
Danis-Lozano R, Díaz-González EE, Trujillo-Murillo KDC, Caballero-Sosa S, Sepúlveda-Delgado J, Malo-García IR, et al. Clinical characterization of acute and convalescent illness of confirmed chikungunya cases from Chiapas, S. Mexico: a cross sectional study. PLoS ONE. 2017;12(10):e0186923.
Sive BR, Patel AK, Kabra SK, Lodha R, Ratageri VH, Ray P. Virus load and clinical features during the acute phase of Chikungunya infection in children. PLoS ONE. 2019;14(2):e0211036.
Acknowledgements
Authors are thankful to The Director, ICMR-NIMR for providing the infrastructure in conducting the study.
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Contributions
AS and DS conceived the study. DS and ARA examined patients and collected patient data. AS, DS, AD, and AT did data analyses. CPY did the statistical analysis. AS, AD, and AT wrote the first draft. AS, DS and ARA revised the manuscript providing critical inputs. AS finalized the manuscript. All authors reviewed and agreed on the finalized manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Ethical Approval and Consent to Participate
Yes, via Institutional Ethics Committee of ICMR-National Institute of Malaria Research approval.
Consent for Publication
Yes.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sinha, A., Savargaonkar, D., De, A. et al. Joint Involvement Can Predict Chikungunya in a Dengue Syndemic Setting in India. J Epidemiol Glob Health 13, 895–901 (2023). https://doi.org/10.1007/s44197-023-00163-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s44197-023-00163-8